In the present study, we examined hepatic gene expressions of key molecules involved in insulin signaling, lipogenesis and gluconeogenesis in both healthy subjects and patients with NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.